The purpose of this study is to calculate the treatment plans and to compare the dose distributions and dose-volume histograms (DVH) for 6 external radiotherapy techniques for the treatment of retinoblastoma as well as intensity-modulated radiotherapy (IMRT) and fractionated stereotactic radiotherapy (Cyberknife).
Methods
Treatment plans were developed using 6 techniques, including an en face electron technique (ET), an anterior and lateral wedge photon technique (LFT), a 3D conformal (6 fields) technique (CRT), an inverse plan IMRT, tomotherapy, and conventional focal stereotactic external beam radiotherapy with Cyberknife (SBRT). Dose volume analyses were carried out for each technique.
Results
All techniques except electron provided similar target coverage. When comparing conformal plan with IMRT and SBRT, there was no significant difference in planning target volume dose distribution. The mean volume of ipsilateral bony orbit received more than 20 Gy, a suggested threshold for bone growth inhibition. The V20 Gy was 73% for the ET, 57% for the LFT, 87% for the CRT, 65% for the IMRT, 66% for the tomotherapy, and 2.7% for the SBRT.
Conclusions
This work supports the potential use of IMRT and SBRT to spare normal tissues in these patients.
CowellJKHungerfordJJayMRutlandPRetinoblastoma: clinical and genetic aspects: a review. J R Soc Med.1988;81 (4):220–223.
2.
AbramsonDHRetinoblastoma: diagnosis and management. CA Cancer J Clin.1982;32 (3):130–140.
3.
FontanesiJTaupJKirkpatricJPHalperinECRetinoblastoma. In Halperin EC, Constine LS, Tarbel NJ, Kun LE, eds. Pediatric Radiation Oncology5th edPhiladelphiaLippincott Williams & Wilkins. 2011: 85–107.
4.
DonaldsonSEgbertPRNewshamICaveneeWKRetinoblastoma. In Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology3th edPhiladelphiaJB Lippincott. 1999: 699–716.
5.
KasteSCChenGFontanesiJCromDBPrattCBOrbital development in long-term survivors of retinoblastoma. J Clin Oncol.1997;15 (3):1183–1189.
6.
BechrakisNEBornfeldNSchuelerACouplandSEHenzeGFoersterMHClinicopathologic features of retinoblastoma after primary chemoreduction. Arch Ophthalmol.1998;116 (7):887–893.
7.
KleinermanRATuckerMATaroneRERisk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol.2005;23 (10):2272–2279.
8.
KleinermanRATuckerMAAbramsonDHSeddonJMTaroneREFraumeniJFJrRisk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst.2007;99 (1):24–31.
9.
McCormickBEllsworthRAbramsonDRadiation therapy for retinoblastoma: comparison of results with lens-sparing versus lateral beam techniques. Int J Radiat Oncol Biol Phys.1988;15 (3):567–574.
10.
HungerfordJLTomaNMPlowmanPNKingstonJEExternal beam radiotherapy for retinoblastoma: I. Whole eye techniqueBr J Ophthalmol.1995;79 (2):109–111.
11.
TomaNMHungerfordJLPlowmanPNKingstonJEDoughtyDExternal beam radiotherapy for retinoblastoma: II. Lens sparing techniqueBr J Ophthalmol.1995;79 (2):112–117.
12.
AertsIPacquementHDozFOutcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut Curie. Eur J Cancer.2004;40 (10):1522–1529.
13.
ShieldsCLShieldsJACaterJOthmaneISinghADMicailyBPlaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology.2001;108 (11):2116–2121.
14.
ShieldsJAShieldsCLDe PotterPCryotherapy for retinoblastoma. Int Ophthalmol Clin.1993;33 (3):101–105.
15.
MurphreeALVillablancaJGDeeganWFIIIChemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol.1996;114 (11):1348–1356.
16.
LumbrosoLDozFUrbietaMChemothermotherapy in the management of retinoblastoma. Ophthalmology.2002;109 (6):1130–1136.
17.
LevyCDozFQuintanaERole of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results. Br J Ophthalmol.1998;82 (10):1154–1158.
18.
GombosDSKellyACoenPGKingstonJEHungerfordJLRetinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age. Br J Ophthalmol.2002;86 (1):80–83.
19.
FriedmanDLHimelsteinBShieldsCLChemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol.2000;18 (1):12–17.
20.
ChanMPHungerfordJLKingstonJEPlowmanPNSalvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation. Br J Ophthalmol.2009;93 (7):891–894.
21.
EldebawyEParkerWAbdel RahmanWFreemanCRDosimetric study of current treatment options for radiotherapy in retinoblastoma. Int J Radiat Oncol Biol Phys.2012;82 (3):e501-e505.
22.
KrasinMJCrawfordBTZhuYEvansESSontagMRKunLEMerchantTEIntensity-modulated radiation therapy for children with intraocular retinoblastoma: potential sparing of the bony orbit. Clin Oncol.2004;16:215–222.
23.
ReisnerMLViégasCMGrazziotinRZRetinoblastoma: comparative analysis of external radiotherapy techniques, including an IMRT technique. Int J Radiat Oncol Biol Phys.2007;67 (3):933–941.
24.
DieckmannKGeorgDZehetmayerMRottenfusserAPötterRStereotactic photon beam irradiation of uveal melanoma: indications and experience at the University of Vienna since 1997. Strahlenther Onkol.2007;183 (Spec No 2): 11–13.
25.
MunierFLVerweyJPicaANew developments in external beam radiotherapy for retinoblastoma: from lens to normal tissue-sparing techniques. Clin Experiment Ophthalmol.2008;36 (1):78–89.
26.
SahgalAMillarBAMichaelsHFocal stereotactic external beam radiotherapy as a vision-sparing method for the treatment of peripapillary and perimacular retinoblastoma: preliminary results. Clin Oncol.2006;18 (8):628–634.
27.
PicaAMoeckliRBalmerAPreliminary experience in treatment of papillary and macular retinoblastoma: evaluation of local control and local complications after treatment with linear accelerator-based stereotactic radiotherapy with micromultileaf collimator as second-line or salvage treatment after chemotherapy. Int J Radiat Oncol Biol Phys.2011;81 (5):1380–1386.
28.
SilberJHLittmanPSMeadowsATStature loss following skeletal irradiation for childhood cancer. J Clin Oncol.1990;8:304–312.
29.
EifelPJDonaldsonSSThomasPRMResponse of growing bone to irradiation: a proposed late effects scoring system. Int J Radiat Oncol Biol Phys.1995;31:1301–1307.
30.
ParsonsJTBovaFJFitzgeraldCRMendenhallWMMillionRRSevere dry-eye syndrome following external beam irradiation. Int J Radiat Oncol Biol Phys.1994;30 (4):775–780.
31.
WongFLBoiceJDJrAbramsonDHCancer incidence after retinoblastoma. Radiation dose and sarcoma riskJAMA.1997;278 (15):1262–1267.
32.
MollACImhofSMSchouten-Van MeeterenAYKuikDJHofmanPBoersMSecond primary tumors in hereditary retinoblastoma: a register-based study, 1945-1997: is there an age effect on radiation-related risk?Ophthalmology.2001;108 (6):1109–1114.
33.
MerchantTEGouldCJHiltonNEOcular preservation after 36 Gy external beam radiation therapy for retinoblastoma. J Pediatr Hematol Oncol.2002;24 (4):246–249.
34.
ShieldsCLRamasubramanianAThangappanAChemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Ophthalmology.2009;116 (3):544–551.
